Clinical presentation of peritoneal mesothelioma

被引:76
|
作者
Acherman, YI
Welch, LS
Bromley, CM
Sugarbaker, PH
机构
[1] Washington Hosp Ctr, Washington Canc Inst, Washington, DC 20010 USA
[2] Washington Hosp Ctr, Dept Occupat & Environm Med, Washington, DC USA
[3] Biostat Solut LLC, Damascus, Syria
关键词
ascites; cytoreductive surgery; intraperitoneal chemotherapy; peritoneal mesothelioma; signs; symptoms;
D O I
10.1177/030089160308900307
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To describe the clinical presentation of peritoneal mesothelioma and its impact on survival. Methods: Data was collected from 51 patients with peritoneal mesothelioma treated at the Washington Cancer Institute. The demographic, clinical and pathologic information were analyzed. Results: Pain was the most common symptom (recorded in 33% of patients); increased abdominal girth occurred in 31%, increased abdominal girth and pain in 5%, and a new onset hernia in 12%. In an additional 14% of patients, a variety of other clinical findings led to the diagnosis. There was a statistically significant difference in survival by gender, weight loss and volume of disease. Conclusions: Pain was the most common initial presenting symptom, with increased abdominal girth as a second. A more favorable prognosis occurred in women with a small disease volume.
引用
收藏
页码:269 / 273
页数:5
相关论文
共 50 条
  • [21] Peritoneal mesothelioma - rare abdominal tumors
    Tannapfel, A.
    Bruecher, B.
    Schlag, P. M.
    ONKOLOGE, 2009, 15 (03): : 250 - +
  • [22] Peritoneal cystic mesothelioma: A case series
    Sethna, K
    Mohamed, F
    Marchettini, P
    Elias, D
    Sugarbaker, PH
    TUMORI JOURNAL, 2003, 89 (01): : 31 - 35
  • [23] Peritoneal mesothelioma.
    Berthet, B
    ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE, 1996, 32 (5-6): : 219 - 221
  • [24] Current Concepts in the Evaluation and Treatment of Patients With Diffuse Malignant Peritoneal Mesothelioma
    Turner, Keli
    Varghese, Sheelu
    Alexander, H. Richard, Jr.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (01): : 49 - 57
  • [25] Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma
    Yan, T. D.
    Yoo, D.
    Sugarbaker, P. H.
    EJSO, 2006, 32 (09): : 948 - 953
  • [26] Surgery for Peritoneal Mesothelioma
    Turner, Keli M.
    Varghese, Sheelu
    Alexander, H. Richard, Jr.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2011, 12 (02) : 189 - 200
  • [27] Focus on Peritoneal Mesothelioma
    Ettahri, H.
    Akkar, O.
    Rais, S.
    Salmi, N.
    Lakhdissi, A.
    Layachi, M.
    Elamarti, L.
    Boutayeb, S.
    Errihani, H.
    JOURNAL AFRICAIN D HEPATO-GASTROENTEROLOGIE, 2016, 10 (04): : 179 - 183
  • [28] Surgery for Peritoneal Mesothelioma
    Keli M. Turner
    Sheelu Varghese
    H. Richard Alexander
    Current Treatment Options in Oncology, 2011, 12 : 189 - 200
  • [29] Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up
    Kusamura, S.
    Kepenekian, V
    Villeneuve, L.
    Lurvink, R. J.
    Govaerts, K.
    De Hingh, I. H. J. T.
    Moran, B. J.
    Van der Speeten, K.
    Deraco, M.
    Glehen, O.
    EJSO, 2021, 47 (01): : 36 - 59
  • [30] Malignant Peritoneal Mesothelioma: Treatment Options and Survival
    Salo, Silja A. S.
    Ilonen, Ilkka
    Laaksonen, Sanna
    Myllarniemi, Marjukka
    Salo, Jarmo A.
    Rantanen, Tuomo
    ANTICANCER RESEARCH, 2019, 39 (02) : 839 - 845